Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

365 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Successful salvage of primary progressive Hodgkin lymphoma with the combination of post-transplant brentuximab vedotin and radiotherapy: Combining novelty and tradition.
Belia M, Chatzidimitriou C, Rondogianni P, Petsa P, Efstathopoulou M, Konstantinou E, Arapaki M, Asimakopoulos J, Plata E, Konstantopoulos K, Angelopoulou MK, Vassilakopoulos TP. Belia M, et al. Among authors: konstantopoulos k. Hematol Oncol. 2021 Apr;39(2):258-262. doi: 10.1002/hon.2801. Epub 2020 Sep 23. Hematol Oncol. 2021. PMID: 32905619 No abstract available.
Central nervous system involvement in primary bone marrow or splenic marginal zone lymphoma: Report of two cases and review of the literature.
Angelopoulou MK, Vassilakopoulos TP, Konstantinou E, Boutsikas G, Asimakopoulos JV, Triantafyllou EF, Petevi K, Kanellopoulos A, Moschogiannis M, Pangalis GA, Siakantaris MP, Konstantopoulos K. Angelopoulou MK, et al. Among authors: konstantopoulos k. Hematol Oncol. 2019 Apr;37(2):219-222. doi: 10.1002/hon.2571. Epub 2019 Feb 1. Hematol Oncol. 2019. PMID: 30592785 Review. No abstract available.
Successful reversal of severe liver function impairment with Brentuximab vedotin in multiply relapsed/refractory classical Hodgkin lymphoma.
Spathas N, Belia M, Giannikos T, Arapaki M, Efstathopoulou M, Tsourouflis G, Gainaru G, Asimakopoulos J, Tsaftaridis P, K Angelopoulou M, Plata E, Konstantopoulos K, P Vassilakopoulos T. Spathas N, et al. Among authors: k angelopoulou m, konstantopoulos k. J BUON. 2019 Nov-Dec;24(6):2483-2489. J BUON. 2019. PMID: 31983123 Free article.
Real-life experience with the combination of polatuzumab vedotin, rituximab, and bendamustine in aggressive B-cell lymphomas.
Dimou M, Papageorgiou SG, Stavroyianni N, Katodritou E, Tsirogianni M, Kalpadakis C, Banti A, Arapaki M, Iliakis T, Bouzani M, Verrou E, Spanoudakis E, Giannouli S, Marinakis T, Mandala E, Mparmparousi D, Sachanas S, Dalekou-Tsolakou M, Hatzimichael E, Vadikolia C, Violaki V, Poziopoulos C, Tsirkinidis P, Chatzileontiadou S, Vervessou E, Ximeri M, Sioni A, Konstantinidou P, Kyrtsonis MC, Siakantaris MP, Angelopoulou MK, Pappa V, Konstantopoulos K, Panayiotidis P, Vassilakopoulos TP. Dimou M, et al. Among authors: konstantopoulos k. Hematol Oncol. 2021 Aug;39(3):336-348. doi: 10.1002/hon.2842. Epub 2021 Mar 2. Hematol Oncol. 2021. PMID: 33583077
Very late relapses in Hodgkin lymphoma treated with chemotherapy with or without radiotherapy: linear pattern and distinct prognostic factors.
Vassilakopoulos TP, Kravvariti E, Panitsas F, Angelopoulou MK, Liaskas A, Kontopidou FN, Yiakoumis X, Variami E, Dimopoulou MN, Siakantaris MP, Asimakopoulos JV, Arapaki M, Dimou M, Diamantopoulos P, Sachanas S, Chatzidimitriou C, Belia M, Konstantinou E, Boutsikas G, Petevi K, Kanellopoulos A, Kokoris S, Kyrtsonis MC, Viniou NA, Lakiotaki E, Tsourouflis G, Korkolopoulou P, Konstantopoulos K, Panayiotidis P, Pangalis GA. Vassilakopoulos TP, et al. Among authors: konstantopoulos k. Blood Cancer J. 2022 Jul 5;12(7):102. doi: 10.1038/s41408-022-00674-w. Blood Cancer J. 2022. PMID: 35790712 Free PMC article. No abstract available.
Prognostic Implication of the Absolute Lymphocyte to Absolute Monocyte Count Ratio in Patients With Classical Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine or Equivalent Regimens.
Vassilakopoulos TP, Dimopoulou MN, Angelopoulou MK, Petevi K, Pangalis GA, Moschogiannis M, Dimou M, Boutsikas G, Kanellopoulos A, Gainaru G, Plata E, Flevari P, Koutsi K, Papageorgiou L, Telonis V, Tsaftaridis P, Sachanas S, Yiakoumis X, Tsirkinidis P, Viniou NA, Siakantaris MP, Variami E, Kyrtsonis MC, Meletis J, Panayiotidis P, Konstantopoulos K. Vassilakopoulos TP, et al. Among authors: konstantopoulos k. Oncologist. 2016 Mar;21(3):343-53. doi: 10.1634/theoncologist.2015-0251. Epub 2016 Feb 26. Oncologist. 2016. PMID: 26921291 Free PMC article.
The Significance of PET/CT in the Initial Staging of Hodgkin Lymphoma: Experience Outside Clinical Trials.
Angelopoulou MK, Mosa E, Pangalis GA, Rondogianni P, Chatziioannou S, Prassopoulos V, Moschogianni M, Tsirkinidis P, Asimakopoulos JV, Konstantinou I, Tsourouflis G, Sachanas S, Yiakoumis X, Boutsikas G, Arapaki M, Gainaru G, Kyrtsonis MC, Siakantaris MP, Datseris I, Panayiotidis P, Konstantopoulos K, Vassilakopoulos TP. Angelopoulou MK, et al. Among authors: konstantopoulos k. Anticancer Res. 2017 Oct;37(10):5727-5736. doi: 10.21873/anticanres.12011. Anticancer Res. 2017. PMID: 28982893
Immunotherapy in Hodgkin Lymphoma: Present Status and Future Strategies.
Vassilakopoulos TP, Chatzidimitriou C, Asimakopoulos JV, Arapaki M, Tzoras E, Angelopoulou MK, Konstantopoulos K. Vassilakopoulos TP, et al. Among authors: konstantopoulos k. Cancers (Basel). 2019 Jul 29;11(8):1071. doi: 10.3390/cancers11081071. Cancers (Basel). 2019. PMID: 31362369 Free PMC article. Review.
Validation of the simplified International Prognostic Score3 in a Hellenic cohort of patients with advanced-stage Hodgkin-lymphoma.
Asimakopoulos JV, Angelopoulou MK, Arapaki MP, Kanellopoulos A, Dimou M, Giakoumis X, Konstantinou E, Belia M, Chatzidimitriou C, Sachanas S, Iliakis T, Kyrtsonis MC, Siakantaris MP, Viniou NA, Variamis E, Kontopidou FN, Pangalis GA, Panayiotidis P, Konstantopoulos K, Vassilakopoulos TP. Asimakopoulos JV, et al. Among authors: konstantopoulos k. Br J Haematol. 2020 Sep;190(6):e335-e339. doi: 10.1111/bjh.16903. Epub 2020 Jun 30. Br J Haematol. 2020. PMID: 32602960 Free article. No abstract available.
365 results